| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 322.784 | 730.161 | 1.306.112 | 1.201.271 |
| Total Income - EUR | - | - | - | - | - | - | 323.941 | 757.951 | 1.324.418 | 1.207.118 |
| Total Expenses - EUR | - | - | - | - | - | - | 52.501 | 352.099 | 1.204.288 | 1.367.895 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 271.440 | 405.852 | 120.130 | -160.777 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 267.151 | 400.455 | 111.567 | -160.777 |
| Employees | - | - | - | - | - | - | 1 | 3 | 4 | 6 |
Check the financial reports for the company - Pharmatalent Europe Inc. S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.833 | 26.006 | 15.632 | 6.794 |
| Current Assets | - | - | - | - | - | - | 272.415 | 436.444 | 609.845 | 108.848 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 25.967 | 142.831 | 303.557 | 98.831 |
| Cash | - | - | - | - | - | - | 246.448 | 293.613 | 306.288 | 10.017 |
| Shareholders Funds | - | - | - | - | - | - | 268.145 | 457.049 | 567.230 | 97.999 |
| Social Capital | - | - | - | - | - | - | 995 | 998 | 995 | 989 |
| Debts | - | - | - | - | - | - | 7.102 | 3.957 | 49.226 | 9.529 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Pharmatalent Europe Inc. S.r.l.